NCT02939300 2025-11-14
Ipilimumab and Nivolumab in Leptomeningeal Metastases
Massachusetts General Hospital
Phase 2 Completed
Clinical Trials
11 trialsNCT04420598 2025-06-24
DEBBRAH
MedSIR
Phase 2 Completed
NCT04233021 2025-02-03
ORBITAL
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Completed
NCT05146219 2024-12-30
Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
TYK Medicines, Inc
Phase 2 Completed
NCT00801216 2024-12-10
SCNSL1
IRCCS San Raffaele
Phase 2 Completed
NCT03082144 2019-08-01
Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors
The First Hospital of Jilin University
Phase 2 Completed
NCT00992602 2017-07-07
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
University of Washington
Phase 2 Completed
NCT02654106 2017-06-06
SRTRBM
ChineseAMS
Phase 2 Completed
NCT00450866 2014-02-28
Epothilone B in Treating Patients With CNS Metastases From Breast Cancer
Case Comprehensive Cancer Center
Phase 2 Completed
NCT01281696 2013-10-16
Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis
National Taiwan University Hospital
Phase 2 Completed
NCT00005811 2013-02-21
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment
National Cancer Institute (NCI)
Phase 2 Completed